Multiple sclerosis is a chronic disease that attacks the central nervous system and affects the brain, spinal cord and optic nerves. Therefore, the success rate of the treatment increases significantly in early diagnosis. The size of the administered stem cells is small enough to pass through the brain cells.The treatment is performed in 3 sessions 45 days apart or in 3 consecutive days. The number of cells to be administered is determined according to the age and weight of the patient.
Patients receiving this treatment at the beginning of the disease may return to their jobs. Stem cell therapy prevents autoimmune inflammation in the brain and repairs damaged brain and spine cells. With Stem Cell Therapy, the progression of the disease is greatly inhibited in MS (Multiple Sclerosis) patients and the existing situation of the patient is improved to a much better level.